bioRxivImmunologyPreprint
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2
P. Desai, C. E. Karl, B. Ying, C.-Y. Liang, T. Garcia-Salum, A. C. Santana, F. T. Caten, J. F. Urban, S. M. Elbashir, D. K. Edwards, S. P. Ribeiro, L. B. Thackray, R.-P. K. Sekaly, M. S. Diamond
Abstract
Although vaccines have reduced COVID-19 disease burden, their efficacy in helminth infection endemic areas is not well characterized. We evaluated the impact of infection by Heligmosomoides polygyrus bakeri (Hpb), a murine intestinal hookworm, on the efficacy of an mRNA vaccine targeting the Wuhan-1 spike protein of SARS-CoV-2. Although immunization generated similar B cell responses in Hpb-infected and uninfected mice, polyfunctional CD4+ and CD8+ T cell responses were markedly reduced in Hpb-infected mice. Hpb-infected and mRNA vaccinated mice were protected against the ancestral SARS-CoV-2 strain WA1/2020, but control of lung infection was diminished against an Omicron variant compared to animals immunized without Hpb infection. Helminth mediated suppression of spike-specific CD8+ T cell responses occurred independently of STAT6 signaling, whereas blockade of IL-10 rescued vaccine-induced CD8+ T cell responses. In mice, intestinal helminth infection impairs vaccine induced T cell responses via an IL-10 pathway and compromises protection against antigenically shifted SARS-CoV-2 variants.
- organism: mouse
- assay: bulk RNA-seq
- assay: flow cytometry
- research focus: host-pathogen & immune response
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Intestinal helminth infection impairs oral and parenteral vaccine efficacy
L. C. Hardy, C. M. Kapita, … O. I. Iweala·bioRxiv·Sep 22, 2022
- Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation
K. L. Hilligan, O. O. Oyesola, … P. Loke·bioRxiv·Nov 9, 2022
- Vaccination against helminth IL-33-modulators permits immune-mediated parasite ejection
Danielle J. Smyth, Suzanne H. Hodge, … Henry J. McSorley·Cell ReportsPeer-reviewed·May 1, 2025
- A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
B. Carter, P. Huang, … D. K. Gifford·bioRxiv·Sep 23, 2022
- Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
J. Garcia-Bernalt Diego, G. Singh, … M. Schotsaert·bioRxiv·May 22, 2023
- Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge
Hong-Su Park, Yumiko Matsuoka, … Cyril Le Nouën·PLoS PathogensPeer-reviewed·Apr 21, 2025